{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:40:39Z","timestamp":1787236839537,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:p>\n                    G protein\u2013coupled receptor kinases (GRKs) are important regulatory proteins for many G protein\u2013coupled receptors, but little is known about\n                    <jats:italic>GRK4<\/jats:italic>\n                    pharmacogenetics. We hypothesized that 3 nonsynonymous\n                    <jats:italic>GRK4<\/jats:italic>\n                    single-nucleotide polymorphisms, R65L (rs2960306), A142V (rs1024323), and A486V (rs1801058), would be associated with blood pressure response to atenolol, but not hydrochlorothiazide, and would be associated with long-term cardiovascular outcomes (all-cause death, nonfatal myocardial infarction, nonfatal stroke) in participants treated with an atenolol-based versus verapamil-SR\u2013based antihypertensive strategy.\n                    <jats:italic>GRK4<\/jats:italic>\n                    single-nucleotide polymorphisms were genotyped in 768 hypertensive participants from the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) trial. In whites and blacks, increasing copies of the variant 65L-142V haplotype were associated with significantly reduced atenolol-induced diastolic blood pressure lowering (\u22129.1\u00b16.8 versus \u22126.8\u00b17.1 versus \u22125.3\u00b16.4 mm Hg in participants with 0, 1, and 2 copies of 65L-142V, respectively;\n                    <jats:italic>P<\/jats:italic>\n                    =0.0088). One thousand four hundred sixty participants with hypertension and coronary artery disease from the INternational VErapamil SR\/Trandolapril STudy (INVEST) were genotyped, and variant alleles of all 3\n                    <jats:italic>GRK4<\/jats:italic>\n                    single-nucleotide polymorphisms were associated with increased risk for adverse cardiovascular outcomes in an additive fashion, with 486V homozygotes reaching statistical significance (odds ratio, 2.29 [1.48\u20133.55];\n                    <jats:italic>P<\/jats:italic>\n                    =0.0002). These effects on adverse cardiovascular outcomes were independent of antihypertensive treatment. These results suggest that the presence of\n                    <jats:italic>GRK4<\/jats:italic>\n                    variant alleles may be important determinants of blood pressure response to atenolol and risk for adverse cardiovascular events. The associations with GRK4 variant alleles were stronger in patients who were also\n                    <jats:italic>ADRB1<\/jats:italic>\n                    389R homozygotes, suggesting a potential interaction between these 2 genes.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.112.198721","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T21:02:53Z","timestamp":1346792573000},"page":"957-964","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":65,"title":["G protein receptor kinase 4 polymorphisms"],"prefix":"10.1161","volume":"60","author":[{"given":"Alexander G.","family":"Vandell","sequence":"first","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian T.","family":"Lobmeyer","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Gawronski","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taimour Y.","family":"Langaee","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gong","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Gums","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber L.","family":"Beitelshees","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Turner","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene B.","family":"Chapman","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda M.","family":"Cooper-DeHoff","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent R.","family":"Bailey","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boerwinkle","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Pepine","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Liggett","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, FL (A.G.V., M.T.L., B.E.G., T.Y.L., Y.G., J.G.G., R.M.C-D., C.J.P., J.A.J.); Department of Community Health and Family Medicine, University of Florida College of Medicine, Gainesville, FL (J.G.G.); Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (A.L.B.); Division..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304013281303"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.09.011"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.108.125955"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.062694599"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.104.531657"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.11.6403"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.03.015"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0301"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00525.x"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.003665"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2008.341"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00068-7"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.03.004"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(02)17734-4"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm930"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01213011-200504000-00006"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1750"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32830967e9"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M206054200"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.11.018"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00423-9"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32810f2e3c"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.139"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200405000-00014"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.07.007"},{"key":"e_1_3_4_27_2","first-page":"29","article-title":"Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial\u2013lipid-lowering arm (ASCOT-LLA).","volume":"12","author":"Lindgren P","year":"2005","unstructured":"Lindgren P, Buxton M, Kahan T, Poulter NR, Dahl\u00f6f B, Sever PS, Wedel H, J\u00f6nsson B; ASCOT investigators. Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial\u2013lipid-lowering arm (ASCOT-LLA). Eur J Cardiovasc Prev Rehabil. 2005;12:29\u201336.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1203\/01.pdr.0000238250.64591.44"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.059139"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.2006.00278.x"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.107.109611"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/48.12.2131"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000219041.66702.45"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.40.24907"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.112.198721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:40:43Z","timestamp":1715578843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.112.198721"}},"subtitle":["\u03b2-Blocker Pharmacogenetics and treatment-related outcomes in Hypertension"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.112.198721"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.112.198721","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"2012-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-08-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-09-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}